Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New rapid blood test could cut hospital referrals for chest pain

NCT ID NCT06853626

Diagnosis Sponsor: University of Oslo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 09, 2026 · Updated 3 times

Summary

This study tests a new rapid blood test that can detect heart damage in about an hour, right in emergency primary care clinics. Researchers will enroll 2,500 adults with chest pain across six Norwegian clinics to see if the test safely rules out heart attacks and reduces hospital referrals. The goal is to improve care for the many patients who have chest pain but no heart attack, while still catching those who need urgent hospital treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
QuidelOrtho TriageTrue hs-cTnI whole-blood assay (a rapid blood test for heart damage)
What this could lead to
If successful, this could allow emergency primary care clinics to quickly rule out heart attacks, reducing unnecessary hospital visits and speeding up care for chest pain patients.
What could go wrong
This is a diagnostic study, not a treatment trial. The test may not be accurate enough in real-world settings, and results may not apply to all patients or clinics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

2,500 people

The number who actually took part.

Started

Jun 2025

Expected to finish

Dec 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients (18+ years) with non-traumatic acute chest pain presenting in emergency primary care * Troponin testing requested by the treating physician Exclusion Criteria: * Acute STEMI (direct hospital referral required) * Haemodynamically unstable (direct hospital referral required) * Not able to provide written, informed consent (i.e., due to time restraints, language barriers, impaired cognitive function, or other reasons)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute coronary syndromes (ACS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute coronary syndrome acute myocardial infarction Chest Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute coronary syndromes (ACS) Acute myocardial infarction (AMI) Chest pain Non-cardiac chest pain Out-of-hours medical care Point of care testing Primary care Troponin

Contacts and locations

Locations

  • Alta Emergency Primary Care Centre

    Alta, Norway

  • Drammen Emergency Primary Care Centre

    Drammen, Norway

  • Fredrikstad and Hvaler Emergency Primary Care Centre

    Fredrikstad, Norway

  • Lyngen Emergency Primary Care Centre

    Lyngseidet, Lyngen, Norway

  • Oslo Accident and Emergency Outpatient Clinic

    Oslo, Norway

  • Trondheim Intermunicipal Emergency Primary Care Centre

    Trondheim, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.